{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T10:14:52Z","timestamp":1788516892287,"version":"build-2803163510"},"reference-count":21,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009776","name":"McMaster University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009776","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jamda.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Medical Directors Association"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jamda.2026.106293","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T19:07:07Z","timestamp":1783105627000},"page":"106293","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pharmacotherapy for Alzheimer's Disease and Dementias in Long-Term Care: A Real-World EHR Study"],"prefix":"10.1016","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3475-0665","authenticated-orcid":false,"given":"Tyler M.","family":"Saumur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huda","family":"Ashraf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine E.","family":"Mathers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittin","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jamda.2026.106293_bib1","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jalz.2005.09.011","article-title":"Undertreatment of patients with Alzheimer\u2019s disease in an elderly United States population","volume":"1","author":"Sano","year":"2005","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.jamda.2026.106293_bib3","doi-asserted-by":"crossref","first-page":"579","DOI":"10.3233\/JAD-200133","article-title":"Pharmaceutical treatment for Alzheimer\u2019s disease and related dementias: utilization and disparities","volume":"76","author":"Barthold","year":"2020","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.jamda.2026.106293_bib4","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/BF03324534","article-title":"Donepezil use in US nursing homes","volume":"16","author":"Pedone","year":"2004","journal-title":"Aging Clin Exp Res"},{"key":"10.1016\/j.jamda.2026.106293_bib5","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1111\/j.1532-5415.2009.02552.x","article-title":"Cholinesterase inhibitor use in U.S. nursing homes: results from the National Nursing Home Survey","volume":"57","author":"Seitz","year":"2009","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jamda.2026.106293_bib6","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1177\/08919887231202948","article-title":"Antidementia medication use in nursing home residents","volume":"37","author":"Ott","year":"2023","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"10.1016\/j.jamda.2026.106293_bib7","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1111\/j.1532-5415.2011.03478.x","article-title":"Cholinesterase inhibitor and memantine use in newly admitted nursing home residents with dementia","volume":"59","author":"Parsons","year":"2011","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jamda.2026.106293_bib8","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/jgs.15069","article-title":"Comparative effectiveness and safety of cognitive enhancers for treating Alzheimer's disease: systematic review and network meta-analysis","volume":"66","author":"Tricco","year":"2018","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jamda.2026.106293_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108352","article-title":"Efficacy of acetylcholinesterase inhibitors in Alzheimer's disease","volume":"190","author":"Marucci","year":"2021","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jamda.2026.106293_bib10","article-title":"Cognitive stimulation to improve cognitive functioning in people with dementia","volume":"2023","author":"Woods","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jamda.2026.106293_bib11","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1532-5415.2005.53117.x","article-title":"Underrecognition of cognitive impairment in assisted living facilities","volume":"53","author":"Magsi","year":"2005","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jamda.2026.106293_bib12","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2011-000380","article-title":"Comparison of cognitive decline between dementia with Lewy bodies and Alzheimer's disease: a cohort study","volume":"2","author":"Walker","year":"2012","journal-title":"BMJ Open"},{"key":"10.1016\/j.jamda.2026.106293_bib13","first-page":"1","article-title":"Cholinesterase inhibitors for Lewy body disorders: a meta-analysis","volume":"19","author":"Matsunaga","year":"2015","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.jamda.2026.106293_bib14","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s40266-014-0154-8","article-title":"Anti-dementia drugs and co-medication among patients with Alzheimer's disease: investigating real-world drug use in clinical practice using the Swedish Dementia Quality Registry (SveDem)","volume":"31","author":"Fereshtehnejad","year":"2014","journal-title":"Drugs Aging"},{"key":"10.1016\/j.jamda.2026.106293_bib15","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.3390\/medicina58101445","article-title":"Polypharmacy in older adults with Alzheimer's disease","volume":"58","author":"Esumi","year":"2022","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.jamda.2026.106293_bib16","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1111\/j.1532-5415.2004.52452.x","article-title":"The Maryland Assisted Living Study: prevalence, recognition, and treatment of dementia and other psychiatric disorders in the assisted living population of Central Maryland","volume":"52","author":"Rosenblatt","year":"2004","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jamda.2026.106293_bib17","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1111\/j.1532-5415.2007.01387.x","article-title":"Treatment of dementia in community-dwelling and institutionalized Medicare beneficiaries","volume":"55","author":"Gruber-Baldini","year":"2007","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jamda.2026.106293_bib18","article-title":"Person-centered care at population scale: the Swedish registry for behavioral and psychological symptoms of dementia","volume":"11","author":"J\u00f6nsson","year":"2025","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.jamda.2026.106293_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2022.101758","article-title":"Effectiveness of treatments for people living with severe dementia: a systematic review and meta-analysis of randomised controlled clinical trials","volume":"82","author":"Profyri","year":"2022","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.jamda.2026.106293_bib20","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jalz.2007.10.016","article-title":"Perspective on race and ethnicity in Alzheimer\u2019s disease research","volume":"4","author":"Weiner","year":"2008","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.jamda.2026.106293_bib21","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.amjopharm.2012.09.002","article-title":"Racial and ethnic disparities in Alzheimer\u2019s disease pharmacotherapy exposure: an analysis across four state Medicaid populations","volume":"10","author":"Gilligan","year":"2012","journal-title":"Am J Geriatr Pharmacother"},{"key":"10.1016\/j.jamda.2026.106293_bib22","series-title":"Medication Use by Medicare Beneficiaries Living in Nursing Homes and Assisted Living Facilities","author":"Briesacher","year":"2002"}],"container-title":["Journal of the American Medical Directors Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525861026001830?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525861026001830?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T09:37:16Z","timestamp":1788514636000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525861026001830"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":21,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1525861026001830"],"URL":"https:\/\/doi.org\/10.1016\/j.jamda.2026.106293","relation":{},"ISSN":["1525-8610"],"issn-type":[{"value":"1525-8610","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacotherapy for Alzheimer's Disease and Dementias in Long-Term Care: A Real-World EHR Study","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Medical Directors Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jamda.2026.106293","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Post-Acute and Long-Term Care Medical Association.","name":"copyright","label":"Copyright"}],"article-number":"106293"}}